181 related articles for article (PubMed ID: 4230117)
1. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
Marder VJ; Shulman NR; Carroll WR
Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117
[No Abstract] [Full Text] [Related]
2. Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis.
Fisher S; Fletcher AP; Alkjaersig N; Sherry S
J Lab Clin Med; 1967 Dec; 70(6):903-22. PubMed ID: 4228698
[No Abstract] [Full Text] [Related]
3. [Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].
Enev N
Vutr Boles; 1978; 17(3):41-5. PubMed ID: 150133
[No Abstract] [Full Text] [Related]
4. Properties of fibrinogenolysis and fibrinolysis products in immune assays.
Beller FK; Maki M
Thromb Diath Haemorrh; 1967 Aug; 18(1-2):114-32. PubMed ID: 4229208
[No Abstract] [Full Text] [Related]
5. Inherited fibrinolytic hyperactivity.
Self J; Matthews C
Arch Intern Med; 1968 Oct; 122(4):357-8. PubMed ID: 5676420
[No Abstract] [Full Text] [Related]
6. A comparative study of adult and fetal sheep fibrinogen, sulf-fibrinogen and fibrinogen degradation products.
Loly W; Israels LG; Bishop AJ; Israels ED
Thromb Diath Haemorrh; 1971 Dec; 26(3):526-40. PubMed ID: 4259443
[No Abstract] [Full Text] [Related]
7. [Natural inhibitors of fibrinolysis and thrombohemorrhagic phenomena].
Moriau M
Pathol Eur; 1969; 4():Suppl 1:9-286. PubMed ID: 4244510
[No Abstract] [Full Text] [Related]
8. Fibrinogen degradation products in experimental intravascular coagulation. Gel filtration and immunological studies.
Zetterqvist E
Acta Physiol Scand; 1971 Jul; 82(3):289-99. PubMed ID: 4108400
[No Abstract] [Full Text] [Related]
9. [Efficiency and limits of fibrinolytic system function tests].
van de Loo J
Internist (Berl); 1973 Apr; 14(4):170-4. PubMed ID: 4577210
[No Abstract] [Full Text] [Related]
10. Nature of the high molecular weight fraction of fibrinolytic digests of human fibrinogen.
Jamieson GA; Gaffney PJ
Biochim Biophys Acta; 1968 Jan; 154(1):96-109. PubMed ID: 4230213
[No Abstract] [Full Text] [Related]
11. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
[No Abstract] [Full Text] [Related]
12. [Fibrinogen and fibrin split products and their biological importance].
Krantz S; Fiedler H; Lober M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):1-13. PubMed ID: 4110779
[No Abstract] [Full Text] [Related]
13. Degradation of fibrinogen in vitro. Demonstration of several antigenic intermediates by specific anti-D and anti-E serum.
Gormsen J; Feddersen C; Clemmensen I; Andersen RB
Scand J Haematol; 1972; 9(6):577-86. PubMed ID: 4118846
[No Abstract] [Full Text] [Related]
14. The effect of fibrinogen degradation products on plasmin activity.
Myśliwiec M; Arnesen H; Godal HC
Thromb Diath Haemorrh; 1973 Jun; 29(3):592-7. PubMed ID: 4271546
[No Abstract] [Full Text] [Related]
15. Fibrin-fibrinogen degradation products in allergic disorders.
Palma-Carlos AG; de Sá A; Joana-Geraldes M; Ducla-Soares J; Migueis-Clode MH
Allergol Immunopathol (Madr); 1974; 2(6):419-22. PubMed ID: 4282697
[No Abstract] [Full Text] [Related]
16. [Relation between fibrinogen concentration, fibrin-stabilizing factor activity and fibrinolysis in hemorrhagic disease in children].
Bebeshko VG; Donskaia SB
Lab Delo; 1987; (7):520-2. PubMed ID: 2442484
[No Abstract] [Full Text] [Related]
17. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
Feddersen C
Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
[No Abstract] [Full Text] [Related]
18. Fibrinogen Valencia. A new case of congenital dysfibrinogenemia.
Aznar J; Fernandez-Pavón A; Regañón E; Vila V; Orellana F
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):564-77. PubMed ID: 4217955
[No Abstract] [Full Text] [Related]
19. [Fibrinogen. Hereditary hypo--and dysfibrinogenemia].
Gajdos A
Nouv Presse Med; 1973 Apr; 2(16):1067-71. PubMed ID: 4267566
[No Abstract] [Full Text] [Related]
20. [Molecular mechanisms of blood coagulation and fibrinolysis activation].
Worowski K
Postepy Hig Med Dosw; 1980; 34(3):189-233. PubMed ID: 6455654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
